Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 24:13:1180559.
doi: 10.3389/fonc.2023.1180559. eCollection 2023.

Editorial: Inflammation and blood diseases, a dog chasing its tail

Affiliations
Editorial

Editorial: Inflammation and blood diseases, a dog chasing its tail

Cosimo Cumbo et al. Front Oncol. .
No abstract available

Keywords: ENKTL; HLH; IBD; MDS; inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Inflammation and blood diseases, a dog chasing its tail

Similar articles

References

    1. Pietras EM. Inflammation: A key regulator of hematopoietic stem cell fate in health and disease. Blood (2017) 130:1693–8. doi: 10.1182/blood-2017-06-780882 - DOI - PMC - PubMed
    1. Hasselbalch HC. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: Is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood (2012) 119:3219–25. doi: 10.1182/blood-2011-11-394775 - DOI - PubMed
    1. Parciante E, Cumbo C, Anelli L, Zagaria A, Redavid I, Minervini A, et al. . The role of NLRP3, a star of excellence in myeloproliferative neoplasms. Int J Mol Sci (2023) 24(5):4860. doi: 10.3390/ijms24054860 - DOI - PMC - PubMed
    1. Hasselbalch HC. Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. a human inflammation model for cancer development? Leuk Res (2013) 37:214–20. doi: 10.1016/J.LEUKRES.2012.10.020 - DOI - PubMed
    1. Cumbo C, Tarantini F, Anelli L, Zagaria A, Redavid I, Minervini CF, et al. . IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis. Exp Hematol Oncol (2021) 10:1–4. doi: 10.1186/s40164-021-00253-y - DOI - PMC - PubMed

Publication types